Literature DB >> 27353586

In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.

Vivek Dhar Dwivedi1, Indra Prasad Tripathi2, Sarad Kumar Mishra3.   

Abstract

BACKGROUND &
OBJECTIVES: NS2B-NS3 protease (NS2B-NS3 pro ) of dengue virus (DENV) is the prime therapeutic target for the development of anti-dengue drug to combat the DENV infection, which is currently an increasing health problem in many countries. In the area of antiviral drug discovery, numerous reports on the antiviral activity of various medicinal plants against dengue viruses have been published. Neem plant (Azadirachta indica) is one among those medicinal plants which is reported to show potential antiviral activity against DENV. But active principle of neem plant extract which has inhibitory potential against DENV NS2B-NS3 pro is not yet reported. The aim of the present study was to explore the inhibitory potential of five triterpenoids from neem plant, viz. nimbin, desacetylnimbin, desacetylsalannin, azadirachtin and salannin, against DENV NS2B-NS3 pro.
METHODS: The molecular 3D structural data of DENV NS2B-NS3 pro and selected triterpenoids of neem plant were collected from protein databank (PDB ID: 2VBC) and PubChem database respectively. The molecular docking approach was employed to find out the in silico inhibitory potential of the five triterpenoids against DENV NS2B- NS3 pro.
RESULTS: The molecular docking results showed that nimbin, desacetylnimbin and desacetylsalannin have good binding affinity with DENV NS2B-NS3 pro , while azadirachtin and salannin did not show any interaction with the target protein. It was observed that the DENV NS2B-NS3 pro binding energy for nimbin, desacetylnimbin and desacetylsalannin were -5.56, -5.24 and -3.43 kcal/mol, respectively. INTERPRETATION &
CONCLUSION: The findings attained through this study on the molecular interaction mode of three neem triterpenoids and DENV NS2B-NS3 pro can be considered for further in vitro and in vivo validation for designing new potential drugs for DENV infection.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27353586

Source DB:  PubMed          Journal:  J Vector Borne Dis        ISSN: 0972-9062            Impact factor:   1.688


  5 in total

1.  Identification of new potent inhibitors of dengue virus NS3 protease from traditional Chinese medicine database.

Authors:  Vivek Dhar Dwivedi; Indra Prasad Tripathi; Shiv Bharadwaj; Aman Chandra Kaushik; Sarad Kumar Mishra
Journal:  Virusdisease       Date:  2016-07-20

Review 2.  Ethnomedicinal herbs in African traditional medicine with potential activity for the prevention, treatment, and management of coronavirus disease 2019.

Authors:  Olutayo Ademola Adeleye; Mbang Nyong Femi-Oyewo; Oluyemisi Adebowale Bamiro; Lateef Gbenga Bakre; Akinyinka Alabi; Joseph Senu Ashidi; Olalekan Adeyinka Balogun-Agbaje; Oluwakemi Mary Hassan; Gbemisola Fakoya
Journal:  Futur J Pharm Sci       Date:  2021-03-20

Review 3.  The Antimicrobial Potential of the Neem Tree Azadirachta indica.

Authors:  Marina R Wylie; D Scott Merrell
Journal:  Front Pharmacol       Date:  2022-05-30       Impact factor: 5.988

Review 4.  Potential of Azadirachta indica as a Capping Agent for Antiviral Nanoparticles against SARS-CoV-2.

Authors:  Frank Eric Tatsing Foka; Nanabi Manamela; Steven Maluta Mufamadi; Hazel Tumelo Mufhandu
Journal:  Biomed Res Int       Date:  2022-09-15       Impact factor: 3.246

Review 5.  Production, Transmission, Pathogenesis, and Control of Dengue Virus: A Literature-Based Undivided Perspective.

Authors:  Muhammad Torequl Islam; Cristina Quispe; Jesús Herrera-Bravo; Chandan Sarkar; Rohit Sharma; Neha Garg; Larry Ibarra Fredes; Miquel Martorell; Mohammed M Alshehri; Javad Sharifi-Rad; Sevgi Durna Daştan; Daniela Calina; Radi Alsafi; Saad Alghamdi; Gaber El-Saber Batiha; Natália Cruz-Martins
Journal:  Biomed Res Int       Date:  2021-12-15       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.